Related Experiment Video
Updated: Jul 5, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Cannabis arteritis
Bernard Noël1, Isabelle Ruf, Renato G Panizzon
1Department of Dermatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. bernard.noel@chuv.ch
Cannabis arteritis, a peripheral vascular disease in young adults, presents a high amputation risk. Early aspirin treatment can achieve arterial revascularization, distinguishing it from irreversible atherosclerosis.
Area of Science:
- Vascular Surgery
- Cardiology
- Toxicology
Background:
- Cannabis arteritis is an emerging peripheral vascular disease linked to cannabis consumption, particularly affecting young adults.
- Increasing European case reports highlight the severity and potential for limb amputation.
- It is frequently misdiagnosed as atherosclerosis, a condition with different treatment implications.
Observation:
- A novel case of cannabis arteritis is presented.
- The patient experienced complete arterial revascularization.
- This positive outcome was achieved with early aspirin administration.
Findings:
- Cannabis arteritis requires distinction from peripheral arterial disease due to atherosclerosis.
- Atherosclerosis-related peripheral arterial disease is typically irreversible.
- Early diagnosis and prompt treatment are crucial for preventing vascular occlusion.
Implications:
- Distinguishing cannabis arteritis from atherosclerosis is vital for appropriate patient management.
- Timely intervention, including aspirin therapy, may prevent irreversible vascular damage and amputation.
- This case underscores the importance of considering cannabis use in young adults presenting with peripheral vascular disease.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Arboviral Encephalitis
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

